Volume 14, Number 11—November 2008
Research
Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus, Rural Southwestern Alaska1
Table 2
Demographic and clinical characteristics for 120 patients infected with MRSA isolates in the prospective collection, southwestern Alaska, 2004–2006*
Characteristic | No. (%) |
---|---|
Sex | |
Male | 61 (50.8) |
Female | 56 (46.7) |
Unknown |
3 (2.5) |
Age, y | |
>1–2 | 11 (9.2) |
3–12 | 14 (11.7) |
13–20 | 22 (18.3) |
21–49 | 53 (44.2) |
>50 | 18 (15.0) |
Unknown |
2 (0.2) |
Location of care | |
Inpatient | 11 (9.2) |
Outpatient | 106 (88.4) |
Emergency department | 59 (49.2) |
Other outpatient | 47 (39.2) |
Unknown |
3 (2.5) |
Place of onset by 72-h rule† | |
Community | 114 (95.0) |
Hospital | 1 (0.8) |
Unknown |
5 (3.3) |
Site of isolation | |
Blood | 3 (2.5) |
Respiratory tract | 1 (0.8) |
Skin/wound | 108 (90.0) |
Urine | 2 (1.7) |
Bone/joint | 1 (0.8) |
Other | 5 (4.2) |
*MRSA, methicillin-resistant Staphylococcus aureus.
†MRSA isolates were considered community onset if they were obtained from a patient in the outpatient setting or from a hospitalized patient within 72 h of admission; only 1 isolate was obtained from a patient who was considered to have had onset of the infection in the hospital.
1Portions of this study were presented at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, September 17–20, 2007, Chicago, IL, USA.